⌘K

Login Start Free

Home/Insiders/Mathias Sheila

MS

SEC Insider//CIK 0001991182

Mathias Sheila

CIK 00019911821 companyBERWYN, PA

Transactions

1

Companies

1

Filings

1

CIK

0001991182

Recent Transactions

1 trade

Award
Virpax Pharmaceuticals, Inc.
Stock Option (right to buy)
2024-01-29+112,000→ 112,000 total

Companies

1

Virpax Pharmaceuticals, Inc.
Chief Scientific Officer

Recent Filings

1

4
Mathias Sheila
Jan 31, 2024

Address

1055 WESTLAKES DRIVE, SUITE 300

BERWYN, PA, 19312

View on SEC.gov